Subscribe To
Astrazeneca signs drug development deal with biotech cellectis
AstraZeneca said on Wednesday it had entered into a collaboration and investment agreement with clinical...
November 1, 2023, 3:17 am
Apnimed announces launch of joint venture with shionogi to develop novel pharmacologic therapies for obstructive sleep apnea and other sleep disorders
$150M transaction supporting early and clinical-stage pipeline development in OSA and related sleep dis...
November 1, 2023, 12:00 am
Lirum therapeutics presents positive data on lx-101, a novel clinical-stage targeted therapy, demonstrating potent preclinical activity against pediatric sarcomas
New York, NY, Oct. 31, 2023 (GLOBE NEWSWIRE) — Lirum Therapeutics, Inc. (“Lirum”), an innovative clinica...
October 31, 2023, 5:27 pm
Cell lysis and disruption market to hit usd 15.5 billion by 2032, growing at a cagr of 12.9% | says transparency market research inc.
Automation in cell lysis and disruption processes is on the rise, allowing for higher throughput and reproducibility. The trend is particularly signif...
October 31, 2023, 4:30 pm
Mersana therapeutics to host third quarter 2023 conference call on november 7, 2023
CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical...
October 31, 2023, 4:30 pm
Revolution medicines to report financial results for third quarter 2023 after market close on november 6, 2023
REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical<...
October 31, 2023, 4:15 pm
Filament health's expertise positions it to tap into multi-billion psychedelics opportunity
Analysts at Water Tower Research have initiated coverage on Filament Health Corp (OTCQB:FLHLF, NEO:FH) with a positive outlook on the firm which they ...
October 31, 2023, 3:44 pm
Eyemd emr healthcare systems inc. announces the release of axon patient engagement at aao 2023
BONITA SPRINGS, Fla., Oct. 31, 2023 (GLOBE NEWSWIRE) — EyeMD EMR, a leading provider of clinical soft...
October 31, 2023, 1:55 pm
Omega therapeutics presents new preclinical data demonstrating pre-transcriptional modulation of multiple cxcl genes by a single epigenomic controller
Coordinated modulation of epigenetic profile of CXCL1-8 genes with corresponding downregulation of gene expression and protein levels, and inhibition ...
October 31, 2023, 11:00 am
Spyglass pharma initiates phase i/ii clinical trial of its intraocular drug delivery platform
Phase I/II trial initiated to investigate innovative SpyGlass platform for the long-term delivery of bimatoprost in patients with glaucoma and visuall...
October 31, 2023, 11:00 am
Context therapeutics reveals ‘encouraging' preclinical data for ctim-76 tumor treatment
Context Therapeutics (NASDAQ:CNTX) Inc has announced what it called encouraging preclinical data regard...
October 31, 2023, 10:12 am
Verve and lilly relationship expands to include verve’s in vivo gene editing programs targeting pcsk9 and angptl3
Lilly Purchases Product Rights to Verve’s Lead Cardiovascular Programs from Beam Therapeutics BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) — Verve Thera...
October 31, 2023, 10:01 am
Xilio to host virtual investor conference call and webcast on monday, november 6, 2023 to review progress across pipeline, including phase 1/2 clinical data for xtx202, a tumor-activated, engineered,
WALTHAM, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-st...
October 31, 2023, 9:15 am
Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting
SAN CARLOS, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, dev...
October 31, 2023, 9:05 am
Fulcrum therapeutics to host third quarter 2023 financial results conference call and webcast on tuesday, november 7, 2023, at 8:00 a.m. et
CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a ...
October 31, 2023, 8:50 am
Perimeter medical imaging ai initiates new clinical trial site at university of washington's fred hutch cancer center
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) said it has initiated an additional clinical tria...
October 31, 2023, 8:08 am
Scancell makes strong progress with lead immunotherapy assets
Key highlights for biotech group Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)'s financial year ending April 30 included a positive data reading arising...
October 31, 2023, 4:48 am
Allogene therapeutics announces participation in november investor conferences
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a c...
October 30, 2023, 8:30 am
Icad to report third quarter 2023 financial results on november 13, 2023
NASHUA, N.H., Oct. 30, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can't hide by...
October 30, 2023, 8:00 am
Kura oncology to participate in three upcoming investor conferences
SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage bioph...
October 30, 2023, 7:30 am